Some types of solid tumors also had MLL2 mutations, although those exhibited a somewhat lower proportion of LOF (11.8% of renal cell carcinoma [28] and 66.7% of medulloblastoma [29] cases). The gene discussed is KMT2D; the disease is medulloblastoma.